These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
492 related articles for article (PubMed ID: 8641348)
1. Goralatide (AcSDKP) selectively protects murine hematopoietic progenitors and stem cells against hyperthermic damage. Wierenga PK; Konings AW Exp Hematol; 1996 Feb; 24(2):246-52. PubMed ID: 8641348 [TBL] [Abstract][Full Text] [Related]
2. Enhanced selectivity of hyperthermic purging of human progenitor cells using Goralatide, an inhibitor of cell cycle progression. Wierenga PK; Brenner MK; Konings AW Bone Marrow Transplant; 1998 Jan; 21(1):73-8. PubMed ID: 9486498 [TBL] [Abstract][Full Text] [Related]
3. Activity of acetyl-n-ser-asp-lys-pro (AcSDKP) on hematopoietic progenitor cells in short-term and long-term murine bone marrow cultures. Jackson JD; Yan Y; Ewel C; Talmadge JE Exp Hematol; 1996 Feb; 24(3):475-81. PubMed ID: 8599978 [TBL] [Abstract][Full Text] [Related]
4. Seraspenide (AcSDKP) mediated protection of hematopoietic stem cells in a hyperthermic purging protocol. Wierenga PK; Konings AW Prog Clin Biol Res; 1994; 389():189-95. PubMed ID: 7700902 [No Abstract] [Full Text] [Related]
5. Studies on the hyperthermic sensitivity of the murine hematopoietic stem cell compartment. I. Heat effects on clonogenic stem cells and progenitors. Wierenga PK; Konings AW Exp Hematol; 1993 May; 21(5):608-13. PubMed ID: 8513860 [TBL] [Abstract][Full Text] [Related]
6. Reduction of heat-induced haemotoxicity in a hyperthermic purging protocol of murine acute myeloid leukaemic stem cells by AcSDKP. Wierenga PK; Dillingh JH; Konings AW Br J Haematol; 1997 Dec; 99(3):692-8. PubMed ID: 9401086 [TBL] [Abstract][Full Text] [Related]
7. The tetrapeptide AcSDKP, an inhibitor of the cell-cycle status for normal human hematopoietic progenitors, has no effect on leukemic cells. Bonnet D; Césaire R; Lemoine F; Aoudjhane M; Najman A; Guigon M Exp Hematol; 1992 Feb; 20(2):251-5. PubMed ID: 1544396 [TBL] [Abstract][Full Text] [Related]
8. A simple, one-step clonal assay allows the sequential detection of committed (CFU-GM-like) progenitors and several subsets of primitive (HPP-CFC) murine progenitors. Ivanović Z; Bartolozzi B; Bernabei PA; Cipolleschi MG; Milenkovic P; Praloran V; DelloSbarba P Stem Cells; 1999; 17(4):219-25. PubMed ID: 10437985 [TBL] [Abstract][Full Text] [Related]
9. Photoprotection of normal human hematopoietic progenitors by the tetrapeptide N-AcSDKP. Coutton C; Guigon M; Bohbot A; Ferrani K; Oberling F Exp Hematol; 1994 Oct; 22(11):1076-80. PubMed ID: 7925774 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of human bone marrow progenitors by the synthetic tetrapeptide AcSDKP. Guigon M; Bonnet D; Lemoine F; Kobari L; Parmentier C; Mary JY; Najman A Exp Hematol; 1990 Nov; 18(10):1112-5. PubMed ID: 2209766 [TBL] [Abstract][Full Text] [Related]
11. The molecular specificity of action of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) in the control of hematopoietic stem cell proliferation. Robinson S; Lenfant M; Wdzieczak-Bakala J; Riches A Stem Cells; 1993 Sep; 11(5):422-7. PubMed ID: 8241953 [TBL] [Abstract][Full Text] [Related]
12. The effect of a combined purging with mafosfamide and hyperthermia on murine haemopoietic stem cells and leukaemogenic cells. Gidáli J; Fehér I Bone Marrow Transplant; 1992 Dec; 10(6):479-83. PubMed ID: 1490197 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory action of the peptide AcSDKP on the proliferative state of hematopoietic stem cells in the presence of captopril but not lisinopril. Chisi JE; Wdzieczak-Bakala J; Riches AC Stem Cells; 1997; 15(6):455-60. PubMed ID: 9402658 [TBL] [Abstract][Full Text] [Related]
14. Catabolism of the tetrapeptide N-Ac-Ser-Asp-Lys-Pro (AcSDKP), an inhibitor of hematopoietic stem cell (CFU-S) proliferation, following in vitro incubation with hematopoietic tissues from normal and leukemic mice. Wdzieczak-Bakala J; Grillon C; Robinson S; Riches A; Carde P; Lenfant M Bull Cancer; 1993 May; 80(5):391-6. PubMed ID: 8173192 [TBL] [Abstract][Full Text] [Related]
15. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice. Drize N; Chertkov J; Samoilina N; Zander A Exp Hematol; 1996 Jun; 24(7):816-22. PubMed ID: 8647232 [TBL] [Abstract][Full Text] [Related]
16. Studies on the hyperthermic sensitivity of the murine hematopoietic stem cell compartment. II. Heat effect on donor stem cells with long-term repopulating ability. Wierenga PK; Konings AW; Down JD Exp Hematol; 1995 Feb; 23(2):108-11. PubMed ID: 7828667 [TBL] [Abstract][Full Text] [Related]
17. Hyperthermic purging in vitro of murine leukemia cells (MK-8057): surviving fractions of normal and leukemic stem cells and the long-term survival of mice injected with the post-hyperthermic leukemia cells. Iwasawa T; Hirabayashi Y; Kubota N; Inoue T; Kakehi M; Matsui K Exp Hematol; 1991 Jun; 19(5):332-7. PubMed ID: 2026185 [TBL] [Abstract][Full Text] [Related]
18. Role of cytoprotective mechanisms in the photochemical purging of autologous bone marrow grafts. Yamazaki T; Sato Y; Sieber F Exp Hematol; 1997 Jul; 25(7):629-37. PubMed ID: 9216739 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of analogues of the tetrapeptide N-Acetyl-Ser-Asp-Lys-Pro (AcSDKP), an inhibitor of primitive haematopoietic cell proliferation. Thierry J; Grillon C; Gaudron S; Potier P; Riches A; Wdzieczak-Bakala J J Pept Sci; 2001 May; 7(5):284-93. PubMed ID: 11428549 [TBL] [Abstract][Full Text] [Related]
20. Comparative heat sensitivity of murine and human hemopoietic progenitors and clonogenic leukemia cells. Gidáli J; Fehér I; Kovács P Stem Cells; 1994 Sep; 12(5):533-8. PubMed ID: 7804126 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]